NASDAQ:ADMS Shareholder Notice: Investigation over Possible Securities Laws Violations by Adamas Pharmaceuticals, Inc.
An investigation on behalf of investors of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) shares over potential securities laws violations by Adamas Pharmaceuticals, Inc. was announced.
View full press release